Browsing Category

45043 posts
Sixty Percent of Employees Plan to Move Jobs This Year, Aon Study Finds

Sixty Percent of Employees Plan to Move Jobs This Year, Aon Study Finds

Inaugural study of employees in 23 geographies reveals employees are engaging in…
Revolutionizing Crypto: How JuCoin Plans to Reclaim Its Market Throne

Revolutionizing Crypto: How JuCoin Plans to Reclaim Its Market Throne

SINGAPORE, Jan. 14, 2025 /PRNewswire/ — JuCoin (jucoin.com), a prominent centralized cryptocurrency…

Hansen Strengthens Community Solar Reach Across the United States, Targets New Growth Opportunities

Hansen today partners with Community Solar developers across ten US states; primed…

Endogenex™ Appoints Krissy Wright as Chief Financial Officer

Bringing finance, operational, and corporate development expertise to an experienced leadership team.…

ZTE, Nokia, and Huawei Lead ABI Research's 5G FWA CPE Vendor Competitive Ranking

LONDON, Jan. 14, 2025 /PRNewswire/ — A new Competitive Ranking by global…

Argon Medical Expands Oncology Product Offering with Acquisition of the SeQure® and DraKon™ Microcatheters

PLANO, Texas, Jan. 14, 2025 /PRNewswire/ — Argon Medical, a leading provider…
Korea's Leading Indie Beauty Brand d'Alba, Reaches New Heights Globally with 210% Overseas Sales Surge

Korea's Leading Indie Beauty Brand d'Alba, Reaches New Heights Globally with 210% Overseas Sales Surge

SEOUL, South Korea, Jan. 14, 2025 /PRNewswire/ — Premium vegan beauty brand d’Alba…

ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS

SEOUL, South Korea, Jan. 14, 2025 /PRNewswire/ — ImmunoForge announced that it…